Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412Joseph D. Growney(Novartis (Switzerland)), D. Gary Gilliland(Novartis (Switzerland))BloodMarch 25, 200510.1182/blood-2004-12-4617Cited by 250SaveCiteExport RISWatch citationsRelated PapersTransformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes|The EMBO Journal|1998|250